Liver Failure/Cirrhosis/Portal Hypertension
Article first published online: 14 OCT 2012
Copyright © 2012 American Association for the Study of Liver Diseases
Volume 56, Issue 5, pages 1849–1860, November 2012
How to Cite
Coll, M., Rodriguez, S., Raurell, I., Ezkurdia, N., Brull, A., Augustin, S., Guardia, J., Esteban, R., Martell, M. and Genescà, J. (2012), Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats. Hepatology, 56: 1849–1860. doi: 10.1002/hep.25845
Potential conflict of interest: Nothing to report.
Nahia Ezcurdia and Sarai Rodríguez are recipients of a predoctoral fellowship grant from the VHIR and enrolled in the postgraduate program of the Department of Medicine of the Universitat Autònoma de Barcelona. Imma Raurell is a recipient of a fellowship grant from the Instituto de Salud Carlos III. Salvador Augustin is a recipient of a “Rio Hortega” fellowship grant from the Instituto de Salud Carlos III. CIBERehd is supported by Instituto de Salud Carlos III. The study was funded by a grant from Ministerio de Ciencia e Innovación (MICINN) SAF2009-08354. Chelsea Therapeutics Inc. has not contributed financially to this work.
- Issue published online: 31 OCT 2012
- Article first published online: 14 OCT 2012
- Accepted manuscript online: 18 MAY 2012 11:49AM EST
- Manuscript Accepted: 7 MAY 2012
- Manuscript Received: 5 DEC 2011
Additional Supporting Information may be found in the online version of this article.
|HEP_25845_sm_SuppFig1.tif||8506K||Supporting Information Figure 1.|
|HEP_25845_sm_SuppFig2.tif||8502K||Supporting Information Figure 2.|
|HEP_25845_sm_SuppFig3.tif||8503K||Supporting Information Figure 3.|
|HEP_25845_sm_SuppTable.doc||21K||Supporting Information Table 1.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.